Showing 2961-2970 of 8921 results for "".
DermWireTV: NPF on Boosters; Galderma Raises Awareness, World Eczema Day, and more
https://practicaldermatology.com/topics/psoriasis/dermwiretv-npf-on-boosters-galderma-raises-awareness-world-eczema-day-and-more/20002/Launched on World Eczema Day, the Global Patient Initiative to Improve Eczema Care represents 11 patient organizations from eight countries. The initiative is supported with funding from LEO Pharma. GlobalSkin marked World Eczema Day by calling on health care professionals, health policy decision maThe Economical ADVANTAGE Diode Laser Treats Chest and Abs Hair In Under 5 Minutes
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/the-economical-advantage-diode-laser-treats-chest-and-abs-hair-in-under-5-minutes/19213/ADVANTAGE™ Diode Laser Hair Removal System, offers clinics an economical way to have speed and efficacy in a small footprint. The 10 x 30 mm handpiece delivers impressive speed for efficacious LHR as demonstrated by Dr. Melanie Palm. The male patient in this video has his unwanted chest and abs hairYour Website Architecture - Every Brick Counts, an Ekwa.com Educational Video
https://practicaldermatology.com/topics/practice-management/your-website-architecture-every-brick-counts/19340/An educational video explaining proper website architecture and menu placement for External uses. Visit Ekwa.com for more information.DermwireTV: DermaRite Issues Recall for Several Hand Soaps
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-dermarite-issues-recall-for-several-hand-soaps/37113/In this episode, new research shows switching between interclass biologics may be safe and effective for psoriasis patients; DermaRite recalls 4 skin care products over contamination concerns; and awareness grows for generalized pustular psoriasis through a new global awareness campaign.Study Examines Socioeconomic Status and HS Diagnosis
https://practicaldermatology.com/series/dermwire-tv/study-examines-socioeconomic-status-and-hs-diagnosis/35859/In this week's DermwireTV, a new study examines the association between socioeconomic status and HS diagnosis; a new meta-analysis highlights the therapeutic potential of simvastatin for vitiligo; and in our “Updates on Skin Cancer” feature, we hear about how to use gene expression profile testing fRecent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20850/SCALE Notes
https://practicaldermatology.com/issues/supplements/scale-notes/22088/News and views from Music City SCALERepairing the Ellipse; Resident Salary Update
https://practicaldermatology.com/youngmd-connect/resident-resource-center/repairing-the-ellipse-resident-salary-update/20414/Antioxidants and Skin Cancer Risk: A Look at Vitamins A and B
https://practicaldermatology.com/topics/skin-cancer-photoprotection/antioxidants-and-skin-cancer-risk-a-look-at-vitamins-a-and-b/23106/There is some evidence to suggest that higher intake of these antioxidants may reduce skin cancer risks.First Medication for Severe Frostbite; Biosimilar to Humira with Interchangeability Status Approved; Two Late-Stage AD Candidates Advance
https://practicaldermatology.com/series/dermwire-tv/first-medication-for-severe-frostbite-biosimilar-to-humira-with-interchangeability-status-approved-two-late-stage-ad-candidates-advance/20267/In this episode of DermWireTV, the first medication to treat severe frostbite is approved by the FDA; the first high-concentration biosimilar to Humira with interchangeability status will soon be available in the US; and two companies with late-stage atopic dermatitis candidates provide key updates.